The Short-term Impact of Symptom-defined COPD Exacerbation Recovery on Health Status and Lung Function

被引:11
作者
Murray, Lindsey T. [1 ]
Leidy, Nancy K. [1 ]
机构
[1] Evidera, Bethesda, MD USA
来源
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION | 2018年 / 5卷 / 01期
关键词
COPD; exacerbations; EXACT; patient-reported outcomes; outcome measures; health status; lung function; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; RESPIRATORY SYMPTOMS; NEUTROPHIL ELASTASE; CLINICAL-TRIALS; GLOBAL BURDEN; TIME-COURSE; TOOL EXACT; DIARY; QUESTIONNAIRE;
D O I
10.15326/jcopdf.5.1.2017.0166
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study examined the short-term effects of symptom-defined exacerbation recovery on health status and pulmonary function in moderate to severe chronic obstructive pulmonary disease (COPD) patients. Methods: Secondary analyses of pooled data from two 12-week Phase II international, randomized controlled trials using the EXAcerbations of Chronic Pulmonary Disease Tool (EXACT) to identify symptom-defined exacerbations were conducted. Recovery was categorized as recovered, unrecovered (persistent worsening), or censored. Multiple regression analyses were used to test the effect of recovery status on change in the St George's Respiratory Questionnaire (SGRQ) and forced expiratory volume in 1 second (FEV1) from baseline to Week 12. Evaluating Respiratory Symptom scale (E-RS) scores were used to evaluate change in stable-state respiratory symptoms from baseline to Week 12. Results: Of 1346 eligible patients, 414 (31%) experienced >= 1 symptom-defined exacerbation; 260 patients recovered from their events, 80 experienced an unrecovered event (persistent worsening), 74 patients had only censored events (excluded). Groups were similar at baseline, with the recovered group reporting significantly worse symptoms (p<0.01). Recovery group and baseline SGRQ were significant predictors of change in health status over 12 weeks (p=0.04; p<0.01); no effects were observed for lung function. Significant between-group differences in change in respiratory symptom severity from baseline to Week 12 were observed (p<0.01), with the persistent worsening group experiencing clinically meaningful deterioration in breathlessness and chest symptoms. Conclusions: Results suggest some patients have difficulty recovering from symptom-defined exacerbations, leading to a deterioration in health status, dyspnea, and chest symptoms without short-term effects on lung function. Further study of symptom-defined exacerbation recovery and health outcomes is warranted.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 37 条
[1]   Time course and pattern of COPD exacerbation onset [J].
Aaron, Shawn D. ;
Donaldson, Gavin C. ;
Whitmore, George A. ;
Hurst, John R. ;
Ramsay, Tim ;
Wedzicha, Jadwiga A. .
THORAX, 2012, 67 (03) :238-243
[2]  
[Anonymous], 2015, GLOB STRAT DIAGN MAN
[3]   COPD exacerbations: definitions and classifications [J].
Burge, S ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :46S-53S
[4]   Relationship between respiratory symptoms and medical treatment in exacerbations of COPID [J].
Calverley, P ;
Pauwels, R ;
Lofdahl, CG ;
Svensson, K ;
Higenbottam, T ;
Carlsson, LG ;
Ståhl, E .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) :406-413
[5]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[6]   Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease [J].
Donaldson, Gavin C. ;
Law, Martin ;
Kowlessar, Beverly ;
Singh, Richa ;
Brill, Simon E. ;
Allinson, James P. ;
Wedzicha, Jadwiga A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (08) :943-950
[7]   Longitudinal changes in the nature, severity and frequency of COPD exacerbations [J].
Donaldson, GC ;
Seemungal, TAR ;
Patel, IS ;
Lloyd-Owen, SJ ;
Wilkinson, TMA ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :931-936
[8]  
Ehsan Mohsin, 2013, Ann Am Thorac Soc, V10, P559, DOI 10.1513/AnnalsATS.201304-100OC
[9]   The clinical and economic burden of chronic obstructive pulmonary disease in the USA [J].
Guarascio, Anthony J. ;
Ray, Shaunta M. ;
Finch, Christopher K. ;
Self, Timothy H. .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 :235-245
[10]   The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies [J].
Jones, Paul W. ;
Leidy, Nancy K. ;
Hareendran, Asha ;
Lamarca, Rosa ;
Chuecos, Ferran ;
Gil, Esther Garcia .
RESPIRATORY RESEARCH, 2016, 17